Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11196449rdf:typepubmed:Citationlld:pubmed
pubmed-article:11196449lifeskim:mentionsumls-concept:C0005496lld:lifeskim
pubmed-article:11196449lifeskim:mentionsumls-concept:C0021467lld:lifeskim
pubmed-article:11196449lifeskim:mentionsumls-concept:C0052794lld:lifeskim
pubmed-article:11196449lifeskim:mentionsumls-concept:C0021469lld:lifeskim
pubmed-article:11196449lifeskim:mentionsumls-concept:C1709634lld:lifeskim
pubmed-article:11196449lifeskim:mentionsumls-concept:C0964818lld:lifeskim
pubmed-article:11196449lifeskim:mentionsumls-concept:C2745441lld:lifeskim
pubmed-article:11196449pubmed:issue4lld:pubmed
pubmed-article:11196449pubmed:dateCreated2001-1-24lld:pubmed
pubmed-article:11196449pubmed:abstractTextThe interaction of several biogenic amines and Compound A (2-(4-acetoxyphenyl)-2-chloro- N-methyl-ethylammonium chloride), an analogue of the active substance in a HPLC fraction isolated from the shrub, Salsola tuberculatiformis Botsch., with cytochrome P450c11 was investigated. Noradrenaline, octopamine and Compound A inhibited the type I DOC induced difference spectrum of P450c11 and elicited a type II difference spectrum when added alone. The Ks-values for noradrenaline, octopamine, and Compound A were 0.8 mM, 0.16 mM and 0.36 mM, respectively. Dopamine, adrenaline and synephrine did not interact with, or inhibit, P450c11. Further investigation of Compound A indicated that it is a mixed inhibitor of sheep P450c11 with a stronger competitive (Kic = 106-110 microM) than uncompetitive (Kiu = 667-737 microM) element, and that it inhibits the conversion of deoxycorticosterone to corticosterone by human 11beta-hydroxylase and aldosterone synthase with EC50 values of 97 microM and 190 microM, respectively, in fetal calf serum.lld:pubmed
pubmed-article:11196449pubmed:languageenglld:pubmed
pubmed-article:11196449pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11196449pubmed:citationSubsetIMlld:pubmed
pubmed-article:11196449pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11196449pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11196449pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11196449pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11196449pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11196449pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11196449pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11196449pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11196449pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11196449pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11196449pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11196449pubmed:statusMEDLINElld:pubmed
pubmed-article:11196449pubmed:monthNovlld:pubmed
pubmed-article:11196449pubmed:issn0743-5800lld:pubmed
pubmed-article:11196449pubmed:authorpubmed-author:SwartA CAClld:pubmed
pubmed-article:11196449pubmed:authorpubmed-author:LouwAAlld:pubmed
pubmed-article:11196449pubmed:authorpubmed-author:StockR GRGlld:pubmed
pubmed-article:11196449pubmed:authorpubmed-author:AngusS PSPlld:pubmed
pubmed-article:11196449pubmed:issnTypePrintlld:pubmed
pubmed-article:11196449pubmed:volume26lld:pubmed
pubmed-article:11196449pubmed:ownerNLMlld:pubmed
pubmed-article:11196449pubmed:authorsCompleteYlld:pubmed
pubmed-article:11196449pubmed:pagination729-36lld:pubmed
pubmed-article:11196449pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:11196449pubmed:meshHeadingpubmed-meshheading:11196449...lld:pubmed
pubmed-article:11196449pubmed:meshHeadingpubmed-meshheading:11196449...lld:pubmed
pubmed-article:11196449pubmed:meshHeadingpubmed-meshheading:11196449...lld:pubmed
pubmed-article:11196449pubmed:meshHeadingpubmed-meshheading:11196449...lld:pubmed
pubmed-article:11196449pubmed:meshHeadingpubmed-meshheading:11196449...lld:pubmed
pubmed-article:11196449pubmed:meshHeadingpubmed-meshheading:11196449...lld:pubmed
pubmed-article:11196449pubmed:meshHeadingpubmed-meshheading:11196449...lld:pubmed
pubmed-article:11196449pubmed:meshHeadingpubmed-meshheading:11196449...lld:pubmed
pubmed-article:11196449pubmed:meshHeadingpubmed-meshheading:11196449...lld:pubmed
pubmed-article:11196449pubmed:meshHeadingpubmed-meshheading:11196449...lld:pubmed
pubmed-article:11196449pubmed:meshHeadingpubmed-meshheading:11196449...lld:pubmed
pubmed-article:11196449pubmed:meshHeadingpubmed-meshheading:11196449...lld:pubmed
pubmed-article:11196449pubmed:meshHeadingpubmed-meshheading:11196449...lld:pubmed
pubmed-article:11196449pubmed:meshHeadingpubmed-meshheading:11196449...lld:pubmed
pubmed-article:11196449pubmed:year2000lld:pubmed
pubmed-article:11196449pubmed:articleTitleInhibition of cytochrome P450c11 by biogenic amines and an aziridine precursor, 2-(4-acetoxyphenyl)-2-chloro-N-methyl-ethylammonium chloride.lld:pubmed
pubmed-article:11196449pubmed:affiliationDepartment of Biochemistry, University of Stellenbosch, South Africa.lld:pubmed
pubmed-article:11196449pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11196449lld:pubmed